Corporate Member News

VigiLanz Becomes First Clinical Intelligence Platform to Integrate Sanford Guide Infectious Disease Content

VigiLanz, a digital healthcare intelligence firm, and Antimicrobial Therapy Inc., publisher and developer of The Sanford Guide, announced today an exclusive partnership that brings together the market-leading clinical intelligence platform and the industry's top digital infectious disease content. Doing so provides VigiLanz users with the critical next step in the clinical surveillance process -- access to peer-reviewed recommendations on the latest treatments for improved patient outcomes.